CJC-1295 & ipamorelin cost in 2026: what the blend actually costs per month

Almost nobody buys CJC-1295 and ipamorelin one at a time. They are marketed, shipped and billed as a single combined blend in one vial — a long-lasting GHRH-analog component paired with a selective ghrelin-receptor secretagogue — which means the “CJC-1295 ipamorelin cost” you keep seeing quoted is the price of the bundle, not the sum of two line items. That bundling is the whole reason the numbers are confusing. Below is how the blend is actually priced in mid-2026, what makes one monthly figure twice another, and the question the price tag never answers: whether the evidence justifies the spend at all.

Why it’s a blend price, not two prices

The two molecules sit at different points on the same growth-hormone axis. CJC-1295 acts as a long-duration GHRH analog; ipamorelin is a selective secretagogue that triggers a GH pulse through the ghrelin receptor with comparatively little spillover onto cortisol or prolactin.^[1] Sellers pair them because the two pathways are complementary, and then they reconstitute both into one vial. The practical consequence for cost is that there is rarely a clean “ipamorelin cost” or a standalone “CJC-1295 cost” to quote — you are pricing a fixed-ratio blend, and the ratio, the total milligrams per vial, and how many vials make a month are all set by the seller. Two listings at very different prices can contain effectively the same peptides at different concentrations, which is why per-vial stickers are nearly useless for comparison and per-month is the only honest unit.

Route 1 — Mail-order telehealth: the common blend price

The most common way a healthy adult buys this pair is a telehealth prescription filled by a compounding pharmacy and mailed monthly. Here the all-in figure — the blend itself, the asynchronous clinician review, and shipping — generally clusters in the ~$150 to $400 a month band, with the spread driven almost entirely by the wrapper rather than the peptides. A longer prepaid plan (three or six months) lowers the effective monthly rate; a month-to-month order with a first-visit intake fee raises it. None of it is touched by insurance, because a compounded GH-secretagogue blend for “wellness” is not a covered indication — it is cash-pay by definition.

Two things to watch on these listings. First, the “intro” price: a low first-month number that steps up on renewal, exactly as it does across the wider compounded-peptide market — the same pattern we traced in our peptide therapy cost breakdown. Second, blend concentration: a cheaper monthly fee can simply mean a lower-milligram vial that runs out sooner, so the true cost per unit of peptide is higher than it looks.

Route 2 — Clinic and concierge programs: paying for the wrapper

In-person and concierge longevity programs carry the widest variance, because the bill is barely tied to the blend at all. You are paying for an intake visit, a baseline lab panel (often IGF-1 and metabolic markers), injection teaching or in-office administration, and frequently an upsell into adjacent services — a stacked peptide course or an IV add-on. An onboarding package bundling consult, labs and the first cycle can run from several hundred dollars to well over a thousand, with monthly maintenance layered on top. The blend inside that program may be chemically identical to the mail-order version; the premium is the clinical envelope around it. That envelope has real value if you genuinely want monitoring — but it is not buying you a better molecule.

Route 3 — The gray market: cheapest sticker, unpriced risk

Search the blend by name and you will find sites selling a “CJC-1295/ipamorelin” vial as a powder labeled for laboratory research and explicitly “not” for people. A per-vial sticker that undercuts the telehealth route by half is the whole sales pitch — yet that research-only label is doing quiet work: a research-only blend lives beyond the reach of any pharmacy oversight, and nobody is confirming the vial holds what its label claims, at the stated ratio, free of contaminants. The closest hard data on that hazard comes from the adjacent gray market for GLP-1 drugs, where a market-surveillance study that actually purchased and lab-tested products sold online without a prescription found unregistered sellers, orders that never arrived, and analyzed content diverging from the label — impurities and dose mismatches included.^[2] A blend bought the same way inherits that identical hazard: what arrives is not a discounted edition of a verified product but an entirely unverified one.

The part the price tag hides: cost versus evidence

Whatever you pay, the honest organizing question is what the blend is proven to do. Here the answer is narrow: both peptides reliably raise growth hormone and IGF-1 — that is a measured pharmacodynamic effect, including in humans for CJC-1295, and the IGF-1 rise is exactly what is seen when GH secretagogues are given to men in a clinical setting.^[3] What does not exist is a body of well-powered human trials showing that the blend builds meaningful muscle, strips fat, or slows aging in healthy adults. So a $150 month and a $400 month are buying the same evidence base — a biomarker story, not an outcome story. That should set the ceiling on what the bundle is worth to you. We grade the underlying support in the peptide evidence matrix, and the full read on these two specifically lives in the ipamorelin & CJC-1295 evidence review.

How the blend compares on price to its neighbors

For context, the closest legitimate alternatives are priced in the same general territory but bought differently. Compounded sermorelin — a single GHRH analog rather than a two-peptide blend — is the cheapest mainstream telehealth GH-axis option, and the oral secretagogue MK-677 is often pitched as a no-needles substitute. If you are weighing the blend against those, our MK-677 vs. sermorelin comparison and the standalone sermorelin evidence review lay out what each one actually buys, so the decision turns on value rather than on which listing flashes the lowest number.

The honest bottom line

“CJC-1295 ipamorelin cost” is really a question about a blend, and the realistic figure for most people is a compounded telehealth vial at roughly $150–$400 a month, cash only, with the variation coming from plan length, blend concentration and whether labs and visits are bundled. Concierge programs cost more because you are buying the clinical wrapper; the gray-market powder looks cheapest in the one transaction where the sticker conceals what you are truly paying. The smart move is not to chase the lowest sticker — it is to anchor whatever you pay to a biomarker-deep evidence base, and to compare the legitimate options on care model as well as price in our peptide therapy provider comparison.